These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15084469)

  • 21. Cellular iron: ferroportin is the only way out.
    Ganz T
    Cell Metab; 2005 Mar; 1(3):155-7. PubMed ID: 16054057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunolocalization and regulation of iron handling proteins ferritin and ferroportin in the retina.
    Hahn P; Dentchev T; Qian Y; Rouault T; Harris ZL; Dunaief JL
    Mol Vis; 2004 Aug; 10():598-607. PubMed ID: 15354085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased DMT1 and increased ferroportin 1 expression is the mechanisms of reduced iron retention in macrophages by erythropoietin in rats.
    Kong WN; Zhao SE; Duan XL; Yang Z; Qian ZM; Chang YZ
    J Cell Biochem; 2008 May; 104(2):629-41. PubMed ID: 18189270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation.
    Jain M; Joharapurkar A; Patel V; Kshirsagar S; Sutariya B; Patel M; Patel H; Patel PR
    Eur J Pharmacol; 2019 Jan; 843():113-120. PubMed ID: 30458168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular control of iron transport.
    Ganz T
    J Am Soc Nephrol; 2007 Feb; 18(2):394-400. PubMed ID: 17229910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs).
    Peyssonnaux C; Zinkernagel AS; Schuepbach RA; Rankin E; Vaulont S; Haase VH; Nizet V; Johnson RS
    J Clin Invest; 2007 Jul; 117(7):1926-32. PubMed ID: 17557118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis.
    Muñoz M; García-Erce JA; Remacha AF
    J Clin Pathol; 2011 Apr; 64(4):281-6. PubMed ID: 21177266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron homeostasis and erythropoiesis.
    Wrighting DM; Andrews NC
    Curr Top Dev Biol; 2008; 82():141-67. PubMed ID: 18282520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del "loss of function" mutations in ferroportin disease.
    Lim FL; Dooley JS; Roques AW; Grellier L; Dhillon AP; Walker AP
    Blood Cells Mol Dis; 2008; 40(3):328-33. PubMed ID: 18160317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iron regulatory and bactericidal properties of human recombinant hepcidin expressed in Pichia pastoris.
    Koliaraki V; Marinou M; Samiotaki M; Panayotou G; Pantopoulos K; Mamalaki A
    Biochimie; 2008 May; 90(5):726-35. PubMed ID: 18295606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different regulatory elements are required for response of hepcidin to interleukin-6 and bone morphogenetic proteins 4 and 9.
    Truksa J; Peng H; Lee P; Beutler E
    Br J Haematol; 2007 Oct; 139(1):138-47. PubMed ID: 17854319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron regulation and erythropoiesis.
    Nemeth E
    Curr Opin Hematol; 2008 May; 15(3):169-75. PubMed ID: 18391780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepcidin expression and iron transport in alveolar macrophages.
    Nguyen NB; Callaghan KD; Ghio AJ; Haile DJ; Yang F
    Am J Physiol Lung Cell Mol Physiol; 2006 Sep; 291(3):L417-25. PubMed ID: 16648237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin.
    Knutson MD; Oukka M; Koss LM; Aydemir F; Wessling-Resnick M
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1324-8. PubMed ID: 15665091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IRP1 regulates erythropoiesis and systemic iron homeostasis by controlling HIF2α mRNA translation.
    Wilkinson N; Pantopoulos K
    Blood; 2013 Aug; 122(9):1658-68. PubMed ID: 23777768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiological focus on the erythropoietin-hepcidin-ferroportin axis.
    D'Anna MC; Roque ME
    Can J Physiol Pharmacol; 2013 May; 91(5):338-45. PubMed ID: 23656253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter.
    Marro S; Chiabrando D; Messana E; Stolte J; Turco E; Tolosano E; Muckenthaler MU
    Haematologica; 2010 Aug; 95(8):1261-8. PubMed ID: 20179090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and clinical heterogeneity of ferroportin disease.
    Cremonesi L; Forni GL; Soriani N; Lamagna M; Fermo I; Daraio F; Galli A; Pietra D; Malcovati L; Ferrari M; Camaschella C; Cazzola M
    Br J Haematol; 2005 Dec; 131(5):663-70. PubMed ID: 16351644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
    Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
    Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of haem and non-haem iron absorption: lessons from inherited disorders of iron metabolism.
    Anderson GJ; Frazer DM; McKie AT; Vulpe CD; Smith A
    Biometals; 2005 Aug; 18(4):339-48. PubMed ID: 16158226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.